E-LIB Suche - Ergebnisse für: de Gramont, A.

1

7P Molecular targeted therapies based on metastatic site in..:

Raeisi, M. ; Cohen, R. ; Chibaudel, B....
ESMO Open. 9 (2024) - p. 102262 , 2024

Link: https://doi.org/10.1016/..

2

Fluoropyrimidine type, patient age, tumour sidedness and mu..:

Karapetis, C. S. ; Liu, H. ; Sorich, M. J....
British Journal of Cancer. 130 (2024) 8 - p. 1269-1278 , 2024

Link: https://doi.org/10.1038/..

3

77P Chronologic improvement in survival of first-line oxali..:

Takeda, Y. ; Yamazaki, K. ; Saltz, L....
Annals of Oncology. 35 (2024) - p. S38 , 2024

Link: https://doi.org/10.1016/..

4

ARCAD-Asia initiative: leveraging yesterday's data for tomo..:

Takeda, Y. ; Misumi, T. ; Bando, H....
ESMO Gastrointestinal Oncology. 2 (2023) - p. 100007 , 2023

Link: https://doi.org/10.1016/..

5

MODUL cohort 2: an adaptable, randomized, signal-seeking tr..:

Tabernero, J. ; Grothey, A. ; Arnold, D....
ESMO Open. 7 (2022) 5 - p. 100559 , 2022

Link: https://doi.org/10.1016/..

6

Prognostic value of primary tumour resection in synchronous..:

van Rooijen, K.L. ; Shi, Q. ; Goey, K.K.H....
European Journal of Cancer. 91 (2018) - p. 99-106 , 2018

Link: https://doi.org/10.1016/..

7

Low-level postoperative carcinoembryonic antigen improves s..:

Auclin, E. ; André, T. ; Taieb, J....
European Journal of Cancer. 97 (2018) - p. 55-56 , 2018

Link: https://doi.org/10.1016/..

8

Understanding c-MET signalling in squamous cell carcinoma o..:

Szturz, P. ; Raymond, E. ; Abitbol, C....
Critical Reviews in Oncology/Hematology. 111 (2017) - p. 39-51 , 2017

Link: https://doi.org/10.1016/..

9

A need to simplify informed consent documents in cancer cli..:

Bleiberg, H. ; Decoster, G. ; de Gramont, A....
Annals of Oncology. 28 (2017) 5 - p. 922-930 , 2017

Link: https://doi.org/10.1093/..

10

Impact of circulating biomarkers in patients with metastati..:

Tijeras-Raballand, A. ; De Gramont, A. ; Chiron, M....
European Journal of Cancer. 69 (2016) - p. S147 , 2016

Link: https://doi.org/10.1016/..

11

Galunisertib combined with sorafenib affects in vivo tumor ..:

Tijeras-Raballand, A. ; Le Bitoux, M.A. ; Maillard, A....
European Journal of Cancer. 69 (2016) - p. S133 , 2016

Link: https://doi.org/10.1016/..

12

2352 Sunitinib as second-line treatment in patients with ad..:

Neuzillet, C. ; Seitz, J.F. ; Fartoux, L....
European Journal of Cancer. 51 (2015) - p. S452 , 2015

Link: https://doi.org/10.1016/..

13

Association of adverse events and survival in colorectal ca..:

Soveri, L.M. ; Hermunen, K. ; de Gramont, A....
European Journal of Cancer. 50 (2014) 17 - p. 2966-2974 , 2014

Link: https://doi.org/10.1016/..

14

406 Aflibercept (Zaltrap) directly attenuates the migration..:

Bouygues, A. ; Mésange, P. ; Ayadi, M....
European Journal of Cancer. 50 (2014) - p. 130 , 2014

Link: https://doi.org/10.1016/..

15

Mélanome cutané avec atteinte ganglionnaire : valeur pronos..:

Deschamps, L. ; Faivre, S. ; Serova, M....
Annales de Dermatologie et de Vénéréologie. 141 (2014) 12 - p. S231 , 2014

Link: https://doi.org/10.1016/..